RESUMO
Emergency start-stop in front of signal lights is one of the main reasons for additional energy consumption and ride discomfort of Electric Vehicle (EV). Existing research on this issue rarely takes into account both energy consumption and ride comfort. Therefore, the layered energy-saving speed planning and control method is proposed. The upper is the layer of energy-saving speed planning. This layer reduces energy consumption of EV by reducing the number of stops on continuous signal lights road and minimizing the range of speed change. On this basis, the sinusoidal variable speed curve is used to smooth the acceleration process to improve ride comfort. Finally, the energy-saving speed considering ride comfort is obtained. This layer makes up for the issue that existing research rarely takes into account both energy consumption and ride comfort of EV, and is an extension and innovation of existing research. The lower is the layer of Model Predictive Controller (MPC)-based speed control. Based on the longitudinal dynamics model of EV, the MPC-based speed controller is established to control EV to track the energy-saving speed. The controller is easy to understand and implement, and it is also suitable for other research on EV, which has certain application value. The simulation results show that under various working conditions, the maximum energy consumption of EV passing through continuous signal lights road without stopping is 604.29 kJ/km, and the minimum is 244.76 kJ/km. The energy consumption is lower than that of actual road test, and it can be saved by 23.18 % compared with the method in the same field. The maximum Root Mean Square of accelerations (RMSa) is 0.25 m/s2, and the minimum is 0.10 m/s2. The values of RMSa above are lower than 0.315 m/s2, which indicates that the ride comfort is good. The utilized method can reduce energy consumption of EV, improve its range and ride comfort, which has important reference significance for promoting the development of EV.
RESUMO
Chronic exposure to solar radiation is the primary cause of photoaging and benign and malignant skin tumors. A conditioned serum-free medium (SFM) was prepared from umbilical cord mesenchymal stem cells (UC-MSCs) and its anti-photoaging effect, following chronic UV irradiation in vitro and in vivo, was evaluated. UC-MSC SFM had a stimulatory effect on human dermal fibroblast proliferation and reduced UVA-induced cell death. In addition, UC-MSC SFM blocked UVA inhibition of superoxide dismutase activity. Topical application of UC-MSC SFM to mouse skin prior to UV irradiation blocked the inhibition of superoxide dismutase and glutathione peroxidase activities, and prevented the upregulation of malonaldehyde. UC-MSC SFM thus protects against photoaging induced by UVA and UVB radiation and is a promising candidate for skin anti-photoaging treatments.
Assuntos
Sobrevivência Celular/efeitos da radiação , Meios de Cultivo Condicionados/química , Fibroblastos/efeitos da radiação , Células-Tronco Mesenquimais/metabolismo , Células-Tronco Mesenquimais/fisiologia , Raios Ultravioleta , Cordão Umbilical/citologia , Animais , Proliferação de Células , Células Cultivadas , Meios de Cultura Livres de Soro/química , Fibroblastos/fisiologia , Glutationa Peroxidase/metabolismo , Humanos , Malondialdeído/metabolismo , Camundongos , Pele/enzimologia , Pele/metabolismo , Pele/efeitos da radiação , Superóxido Dismutase/metabolismoRESUMO
Cofilin1 is an actin-binding protein that plays a critical role in the regulation of actin cytoskeleton and consequently affects various physiological processes. In this study, the human Cofilin1 cDNA was cloned into the expression vector pET-28a(+) with a 6 × His tag and expressed as soluble protein in Escherichia coli BL21(DE3). Approximately 78 mg of Cofilin1, which showed high activity as determined by native PAGE, could be purified from each liter of LB medium by His-tag affinity chromatography and gel filtration. Further, high-titer IgG against Cofilin1 was positively detected after immunization in rabbits and the polyclonal antibodies were purified and identified. Together, this report provides the first protocol to efficiently obtain human Cofilin1 with high biological activity and immunogenicity using E. coli BL21 (DE3) expression system.
Assuntos
Clonagem Molecular , Cofilina 1/genética , Cofilina 1/isolamento & purificação , Animais , Anticorpos/imunologia , Cromatografia de Afinidade , Cofilina 1/química , Cofilina 1/imunologia , DNA Complementar/genética , Escherichia coli/genética , Histidina/genética , Humanos , Imunização , Oligopeptídeos/genética , Coelhos , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/isolamento & purificação , SolubilidadeRESUMO
To investigate the effect of hSCGF-alpha on human Umbilical Cord Mesenchymal Stem Cells (hUCMSCs), we obtained hSCGF-alpha using genetic engineering, hSCGF-alpha gene was amplified from hUCMSCs cDNA using two-step PCR and was inserted into pET-28a(+) plasmid vector. Induced by IPTG at 20 degrees Celsius for 24 h, the fusion protein expressed in E. coli BL21 (DE3) was mainly existing in soluble form. The recombinant hSCGF-a was purified using NI-NTA affinity chromatography and the purity was up to 90%. The colony forming test revealed that combined use hSCGF-alpha and rmGM-CSF (recombinant murine GM-colony stimulating factor, rmGM-CSF) had granulocyte/macrophage (GM) promoting effects on murine bone marrow GM progenitor. In addition, the results indicated that hSCGF-alpha and rhGM-CSF had stimulatory effect on hUCMSCs and their synergetic effect was the strongest.